Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • New hypoglycemic agents and the kidney: what do the major trials tell us?

    F1000Research Date published:

  • Glucose lowering and the kidney: are all drug classes equal?

    The Lancet Diabetes & Endocrinology Date published:

  • Reducing cardiovascular risk in people with diabetes and kidney disease

    Medical Journal of Australia Date published:

  • ACCORDION: Ensuring That We Hear the Music Clearly

    Clinical Journal of the American Society of Nephrology Date published:

  • Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function

    Circulation Date published:

  • New clinical trial designs for establishing drug efficacy and safety in a precision medicine era

    Diabetes, Obesity and Metabolism Date published:

  • Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease

    Cochrane Database of Systematic Reviews Date published:

  • Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

    The Lancet Diabetes & Endocrinology Date published:

  • Letter by Matthews et al Regarding Article, “Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist”

    Circulation Date published:

  • Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus

    Circulation Date published:

  • Canagliflozin and Cardiovascular (CV) Outcomes in Patients with Chronic Kidney Disease

    Diabetes Date published:

  • Acute Increase in Creatinine after Starting ACE Inhibitor and Vascular Events and Premature Death in Patients with Type 2 Diabetes-The ADVANCE Trial

    Diabetes Date published:

  • Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic review

    Diabetes Research and Clinical Practice Date published:

  • Renal trials in diabetes need a platform: time for a global approach?

    The Lancet Diabetes & Endocrinology Date published:

  • Baseline characteristics and enrichment results from the SONAR trial

    Diabetes, Obesity and Metabolism Date published:

  • Trial Design Innovations to Accelerate Therapeutic Advances in Chronic Kidney Disease

    Clinical Journal of the American Society of Nephrology Date published: